Protein induced by vitamin K deficiency II (PIVKA‐II) was identified for the first time in 1968 and was demonstrated to be a potential biomarker supplementing AFP for the diagnosis of HCC in many studies.21, 22, 23. This evidence concerns the gene AFP and hepatocellular carcinoma.